Related Experiment Video

Updated: Oct 10, 2025

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Current state of Ebola virus vaccines: A snapshot

Courtney Woolsey^1,2, Thomas W Geisbert^1,2

¹Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America.

|December 9, 2021

Abstract

No abstract available in PubMed .

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Related Concept Videos

Cross-reactivity

Cross-reactivity

Vaccinations

Vaccinations

Articles linked to this work by shared authors, journal, and citation graph.

Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine.

bioRxiv : the preprint server for biology·2026

Vertical transmission of Nipah virus in an experimentally infected nonhuman primate; a brief report and description of histopathological lesions.

The Journal of infectious diseases·2026

Marburg virus disease: a comprehensive review.

Clinical microbiology reviews·2026

Recombinant Bombali ebolavirus in cynomolgus macaques as a survival model of Ebola virus disease.

Nature communications·2026

Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo Virus.

Pathogens (Basel, Switzerland)·2026

Analysis of Recombinant Cedar Virus Infection and Cross-Protection Against Related Henipaviruses in African Green Monkeys.

Viruses·2026

See all related articles